179 related articles for article (PubMed ID: 21304266)
1. The intrinsic resistome of Pseudomonas aeruginosa to β-lactams.
Alvarez-Ortega C; Wiegand I; Olivares J; Hancock RE; Martínez JL
Virulence; 2011; 2(2):144-6. PubMed ID: 21304266
[TBL] [Abstract][Full Text] [Related]
2. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
Llanes C; Pourcel C; Richardot C; Plésiat P; Fichant G; Cavallo JD; Mérens A;
J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
[TBL] [Abstract][Full Text] [Related]
3. The neglected intrinsic resistome of bacterial pathogens.
Fajardo A; Martínez-Martín N; Mercadillo M; Galán JC; Ghysels B; Matthijs S; Cornelis P; Wiehlmann L; Tümmler B; Baquero F; Martínez JL
PLoS One; 2008 Feb; 3(2):e1619. PubMed ID: 18286176
[TBL] [Abstract][Full Text] [Related]
4. Simple method to determine beta-lactam resistance phenotypes in Pseudomonas aeruginosa using the disc agar diffusion test.
Vedel G
J Antimicrob Chemother; 2005 Oct; 56(4):657-64. PubMed ID: 16144872
[TBL] [Abstract][Full Text] [Related]
5. Chromosomally-encoded resistance mechanisms of Pseudomonas aeruginosa: therapeutic implications.
Lister PD
Am J Pharmacogenomics; 2002; 2(4):235-43. PubMed ID: 12421094
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay.
Okamoto K; Gotoh N; Nishino T
Antimicrob Agents Chemother; 2001 Jul; 45(7):1964-71. PubMed ID: 11408209
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
8. Genetic determinants involved in the susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics.
Alvarez-Ortega C; Wiegand I; Olivares J; Hancock RE; Martínez JL
Antimicrob Agents Chemother; 2010 Oct; 54(10):4159-67. PubMed ID: 20679510
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa populations in the cystic fibrosis lung lose susceptibility to newly applied β-lactams within 3 days.
Tueffers L; Barbosa C; Bobis I; Schubert S; Höppner M; Rühlemann M; Franke A; Rosenstiel P; Friedrichs A; Krenz-Weinreich A; Fickenscher H; Bewig B; Schreiber S; Schulenburg H
J Antimicrob Chemother; 2019 Oct; 74(10):2916-2925. PubMed ID: 31355848
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of beta-lactam resistance amongst Pseudomonas aeruginosa isolated in an Italian survey.
Bonfiglio G; Laksai Y; Franchino L; Amicosante G; Nicoletti G
J Antimicrob Chemother; 1998 Dec; 42(6):697-702. PubMed ID: 10052891
[TBL] [Abstract][Full Text] [Related]
11. A Genetic Screen Reveals Novel Targets to Render
Lee KM; Lee K; Go J; Park IH; Shin JS; Choi JY; Kim HJ; Yoon SS
Front Cell Infect Microbiol; 2017; 7():59. PubMed ID: 28299285
[No Abstract] [Full Text] [Related]
12. Loss of membrane-bound lytic transglycosylases increases outer membrane permeability and β-lactam sensitivity in Pseudomonas aeruginosa.
Lamers RP; Nguyen UT; Nguyen Y; Buensuceso RN; Burrows LL
Microbiologyopen; 2015 Dec; 4(6):879-95. PubMed ID: 26374494
[TBL] [Abstract][Full Text] [Related]
13. Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.
Fournier D; Richardot C; Müller E; Robert-Nicoud M; Llanes C; Plésiat P; Jeannot K
J Antimicrob Chemother; 2013 Aug; 68(8):1772-80. PubMed ID: 23587654
[TBL] [Abstract][Full Text] [Related]
14. Previous ciprofloxacin exposure is associated with resistance to beta-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates.
López-Dupla M; Martínez JA; Vidal F; Almela M; Soriano A; Marco F; López J; Olona M; Mensa J
Am J Infect Control; 2009 Nov; 37(9):753-8. PubMed ID: 19487049
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries.
Castanheira M; Deshpande LM; Costello A; Davies TA; Jones RN
J Antimicrob Chemother; 2014 Jul; 69(7):1804-14. PubMed ID: 24603963
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic Resistance in Pseudomonas.
Laborda P; Hernando-Amado S; Martínez JL; Sanz-García F
Adv Exp Med Biol; 2022; 1386():117-143. PubMed ID: 36258071
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of β-lactam resistance among Pseudomonas aeruginosa.
Wolter DJ; Lister PD
Curr Pharm Des; 2013; 19(2):209-22. PubMed ID: 22894618
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa.
Wi YM; Choi JY; Lee JY; Kang CI; Chung DR; Peck KR; Song JH; Ko KS
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373200
[TBL] [Abstract][Full Text] [Related]
19. Correlation between phenotypic antibiotic susceptibility and the resistome in Pseudomonas aeruginosa.
Jaillard M; van Belkum A; Cady KC; Creely D; Shortridge D; Blanc B; Barbu EM; Dunne WM; Zambardi G; Enright M; Mugnier N; Le Priol C; Schicklin S; Guigon G; Veyrieras JB
Int J Antimicrob Agents; 2017 Aug; 50(2):210-218. PubMed ID: 28554735
[TBL] [Abstract][Full Text] [Related]
20. Comparative Genomics Reveals a Well-Conserved Intrinsic Resistome in the Emerging Multidrug-Resistant Pathogen Cupriavidus gilardii.
Ruiz C; McCarley A; Espejo ML; Cooper KK; Harmon DE
mSphere; 2019 Oct; 4(5):. PubMed ID: 31578249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
